Omnicell rises after lifting lower end of annual profit forecast

** Shares of medical software firm Omnicell OMCL rise 10.3% to $30.15

** OMCL expects 2025 adj. profit forecast in the range of $1.30 to $1.65 per share, compared with previously projected range of $1 to $1.65

** "The updated guidance ranges assume that the potential tariff rate on imports from China returns to 145% after the temporary 90-day reduction period," the company says

** Each 25% reduction below a 145% tariff rate, beginning August 12, represents an expected about $2 million reduction of the impact from the duties on profitability in 2025 - company

** Company expects Q2 adj profit between 24 cents and 34 cents per share vs analysts' estimates 30 cents - data compiled by LSEG

** Company also approved a $75 million stock repurchase program

** Including session's moves, stock down 33.9% YTD